pharmaceuticals

With over 60 million people of childbearing potential in the United States and nearly four million births annually, the continued exclusion of pregnant individuals from clinical drug trials is a critical public health issue.

Astronomically high drug prices are not a new issue in the wild world that is United States healthcare. The U.S. tends to spend far more on the same prescription medications than most of the world, and this has significant impacts on patients’ health and financial outcomes. Forty percent of patients attribute difficulty affording medications as […]